Praxis Precision Medicines
PRAX
PRAX
60 hedge funds and large institutions have $179M invested in Praxis Precision Medicines in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
19% less funds holding
Funds holding: 74 → 60 (-14)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
58% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 24
Holders
60
Holding in Top 10
3
Calls
$252K
Puts
$1K
Top Buyers
| 1 | +$3.42M | |
| 2 | +$2.21M | |
| 3 | +$1.38M | |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$1.16M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.11M |
Top Sellers
| 1 | -$2.51M | |
| 2 | -$1.97M | |
| 3 | -$1.67M | |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.11M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.08M |